$0.83
+0.02 (+2.50%)
Open$0.82
Previous Close$0.81
Day High$0.84
Day Low$0.81
52W High$1.66
52W Low$0.56
Volume—
Avg Volume142.0K
Market Cap12.30M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+5,281.6% upside
Current
$0.83
$0.83
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.89M | 53.74M | 1.67M |
| Net Income | -15,384,074 | -12,219,280 | 470.0K |
| Profit Margin | -25.3% | -24.0% | 28.1% |
| EBITDA | -16,423,739 | -13,769,792 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +13.3% | +13.3% | +24.3% |
| Debt/Equity | 0.44 | 0.44 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |